Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLg Elec Gds S Regulatory News (LGLD)

Share Price Information for Lg Elec Gds S (LGLD)

Share Price is delayed by 15 minutes
Get Live Data
33.20    -6.80 (-17.00%)
Bid:
32.00
Ask:
33.60
Spread: 1.60 (5.00%)
Market Cap: $11.93b
LGLD Live PriceLast checked at - London Stock Exchange

Intraday Lg Elec Gds S Share Chart

  • This share is an international stock.

AGM Statement

2 Mar 2022 07:00

RNS Number : 3462D
LG Electronics Incorporated
02 March 2022
 

2022 LG Electronics AGM Statement

 

Date and location

Date : AM 9:00 March 24th (Thursday), 2022

Location : Main Auditorium (B1), East Wing of LG Twin Towers

 

Agenda

Agenda 1 : Approval of Proposed FY 2021 Financial Statements

 

- Dividend per share : Common Stock 850 KRW, Preferred Stock 900 KRW

Agenda 2 : Approval of Amendment of Article of Incorporation

 

-

 

-

 

 

-

 

-

 

 

In order to sell medical devices, 'medical device manufacturing and sales business' is

to be added in accordance with the Medical Device Act

Addition of 'licensing business of intellectual property rights such as patents' to continue

the intellectual property rights licensing business such as mobile patents, which has been

carried out incidentally by the MC business

Addition of 'development and sales of blockchain-based software, and trading and

brokerage of cryptographic assets' to provide blockchain platform services

'Production and sales of functional materials such as glass powder' is to be added to manufacture/sell functional glass materials (enamel and antibacterial functional glass

powder)

Agenda 3 : Appointment of Directors

 

- Agenda 3-1 : Outside Director Sang-Goo Lee (Re-appointment)- Agenda 3-2 : Outside Director Choong-Yuel Yoo (New appointment)

Agenda 4 : Appointment of Audit Committee Member

 

- Agenda 4-1 : Audit Committee Member Sang-Goo Lee (New appointment)- Agenda 4-2 : Audit Committee Member Choong-Yuel Yoo (New appointment)

Agenda 5 : Approval of Compensation Limit for Directors

 

- Compensation Limit 9.0 Billion KRW (Previous Year : 9.0 Billion KRW)

   

 

 

http://www.rns-pdf.londonstockexchange.com/rns/3462D_1-2022-3-2.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBKBBNABKKANK
Date   Source Headline
29th Apr 20267:16 amRNS1st Quarter Results
15th Apr 20267:00 amRNSFY2025 Consolidated Financial Statement
15th Apr 20267:00 amRNSFY2025 Separate Financial Statement
7th Apr 20267:00 amRNS2026 1Q Pre-earnings Guidance
23rd Mar 202611:45 amRNSResult of AGM
13th Feb 20267:00 amRNSNotice of AGM
30th Jan 20268:47 amRNS2025 4Q Result Report
9th Jan 20267:00 amRNS2025 4Q Pre-earnings Guidance
13th Oct 20257:00 amRNS2025 3Q Pre-earnings Guidance
25th Jul 20257:00 amRNS2025 Half-year Report
7th Jul 20257:00 amRNS2025 2Q Pre-earnings Guidance
24th Apr 20257:00 amRNS1st Quarter Results
16th Apr 20259:09 amRNSFY2024 Consolidated Financial Statement
16th Apr 20259:08 amRNSFY2024 Separate Financial Statement
7th Apr 20257:27 amRNS2025 1Q Pre-earnings Guidance
25th Mar 20257:41 amRNSResult of AGM
20th Feb 20257:05 amRNSNotice of AGM
23rd Jan 20257:05 amRNS4Q 2024 Results Report
8th Jan 20257:00 amRNS2024 4Q Pre-earnings Guidance
24th Oct 20247:42 amRNS3rd Quarter Results
8th Oct 20249:13 amRNS2024 3Q Pre-earnings Guidance
25th Jul 20247:25 amRNS2nd Quarter Results
5th Jul 20248:22 amRNSPRE-EARNINGS GUIDANCE FOR 2Q 2024
12th Jun 20248:50 amRNSFY2023 SEPARATE FINANCIAL STATEMENT
12th Jun 20248:27 amRNSFY2023 CONSOLIDATED FINANCIAL STATEMENT
25th Apr 20247:44 amRNS1st Quarter Results
23rd Apr 20247:00 amRNSFY2023 Consolidated Financial Statement
23rd Apr 20247:00 amRNSFY2023 Separate Financial Statement
5th Apr 20247:00 amRNS2024 1Q PRE-EARNINGS GUIDANCE
26th Mar 20248:39 amRNSResult of AGM
27th Feb 20247:00 amRNSNotice of AGM
25th Jan 20247:00 amRNS4Q 2023 Results Report
8th Jan 20247:15 amRNS2023 4Q PRE-EARNINGS GUIDANCE
27th Oct 20239:00 amRNS3rd Quarter Results
10th Oct 20237:00 amRNS2023 3Q Pre-earnings Guidance
27th Jul 20237:35 amRNS2nd Quarter Results
7th Jul 20237:42 amRNS2023 2Q Pre-earnings Guidance
27th Apr 20239:53 amRNSFY2022 Separate Financial Statement
27th Apr 20239:38 amRNSFY2022 Consolidated Financial Statement
27th Apr 20237:17 amRNS1st Quarter Results
11th Apr 20237:00 amRNS2023 1Q Pre-earnings Guidance
27th Mar 20239:09 amRNSResult of AGM
24th Feb 20237:21 amRNSNotice of AGM
27th Jan 20237:00 amRNS4th Quarter Results
6th Jan 20237:13 amRNS2022 4Q Pre-earnings Guidance
28th Oct 20227:00 amRNS3rd Quarter Results
7th Oct 20228:07 amRNS2022 3Q Pre-earnings Guidance
29th Jul 20227:21 amRNS2nd Quarter Results
7th Jul 20227:51 amRNS2022 2Q Pre-earnings Guidance
28th Apr 20227:23 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.